[From Research & Analysis to Manufacturing, DX, APIs, and Outsourcing] Japan's Largest Exhibition for Pharma, Cosmetics, and Biotech to be Held at Makuhari Messe in May

RX Japan Ltd. (Headquarters: Chuo-ku, Tokyo; President: Takeshi Tanaka) will hold the "28th INTERPHEX Week Tokyo" at Makuhari Messe for three days from May 20 (Wed) to May 22 (Fri), 2026.
Marking its 28th edition, this year's event will feature a change in schedule and venue, moving to May at Makuhari Messe.

INTERPHEX Week is one of Japan's largest exhibitions covering R&D, analysis, manufacturing, quality control, packaging, outsourcing, and DX in the pharmaceutical, cosmetics, and biotechnology sectors. Pharmaceutical and cosmetics manufacturers, research institutions, and biotech-related companies from around the world will attend to engage in practical business negotiations through the latest technologies and live equipment demonstrations.

■ 6 Specialized Exhibitions + Regenerative Medicine EXPO

The event consists of six specialized exhibitions.

These include INTERPHEX JAPAN, specializing in pharmaceutical manufacturing and packaging technology; INPHARMA JAPAN, focusing on APIs, intermediates, additives, and contract synthesis services; BioPharma EXPO, dedicated to biopharmaceutical R&D and manufacturing technology; PharmaLab EXPO, featuring the latest equipment for pharmaceutical research and development; and Pharma DX EXPO, a specialized exhibition solving DX challenges in the pharmaceutical industry.

Furthermore, this year we are launching a new specialized exhibition: CMO / CDMO EXPO, themed around contract development and manufacturing for pharmaceuticals. Against the backdrop of government policies aimed at strengthening drug discovery capabilities, improving the international competitiveness of the pharmaceutical industry, and reinforcing supply chains, the strategic use of CMOs/CDMOs is gaining attention. This exhibition was established in response to strong demand from visiting pharmaceutical manufacturers.

Additionally, the Regenerative Medicine EXPO, where research and manufacturing technologies for regenerative medicine and cell therapy are showcased, will be held concurrently.

■ 950 Companies Showcasing Featured Products, Plus 320 Seminars

This year, 950 companies will exhibit, allowing attendees to compare and evaluate the latest equipment and new products. International participation is also increasing, with exhibitors confirmed from 25 countries and regions worldwide, including the U.S., Europe, China, South Korea, and Taiwan. The event covers the entire industry, from pharmaceutical raw materials to R&D, manufacturing, quality control, and logistics. A wide range of products will be on display, from the latest research equipment and manufacturing facilities to production DX solutions and sustainable packaging. For researchers and engineers at pharmaceutical companies, this event offers hints and solutions to help solve their challenges.